- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- omniome.com
- Total Funding
- $133.0M
- Last Round
- $60.0M Series CJan 2020
- Rounds
- 3
- Acquired by
- PacBioSep 2021 · $600.0M
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Omniome developed a proprietary short-read DNA sequencing platform based on Sequencing by Binding (SBB) chemistry. Acquired by PacBio in September 2021 for ~$800 million.
Summary
Omniome is a Biotech company based in San Diego, United States, founded in 2013. It has raised $133.0M in total across 3 rounds, most recently a $60.0M Series C round in Jan 2020. Investors include Decheng Capital, Pacific Biosciences and Madrone Capital Partners.
Funding & Exit History
Jul 2021
Sign up to see all 4 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/omniome"><img src="https://indexed.vc/api/badge/company/omniome" alt="Omniome on Indexed.vc" width="260" height="76" /></a>